5 Results for "

KMS-11

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "KMS-11" in MCE Product Catalog:

Cat. No.: HY-145103
CAS No.: 2561494-77-5
Purity:  99.15%
Research Areas:  

Cancer

UNC6934 is a selective NSD2-PWWP1 antagonist with a Kd of 91 nM against human targets. UNC6934 binds to the canonical methyl-lysine binding pocket of NSD2-PWWP1 and directly competes with H3K36me2 for binding. UNC6934 induces the aggregation of NSD2 within the nucleolus, without altering ribosomal RNA transcription, global H3K36me2 levels or the proliferation of KMS-11 cells. UNC6934 can be used in studies related to multiple myeloma and diffuse intrinsic pontine glioma .
loading...
    loading...
Cat. No.: HY-122657
CAS No.: 1881276-00-1
Purity:  98.92%
Target:  

RUNX

Research Areas:  

Cancer

AI-10-104 is an inhibitor for runt-related transcription factor (RUNX), which enhances the cytotoxicity in myeloma cells .
loading...
    loading...
Cat. No.: HY-107194
CAS No.: 102586-30-1
Purity:  99.07%
NSC12 is an orally active pan-FGF trap. NSC12 inhibits the interaction between FGF2/FGFR. NSC12 suppresses the phosphorylation of FGFR3. NSC12 reduces c-Myc levels, induces DNA damage, triggers the cleavage of Caspase 3, and promotes ROS production. NSC12 exhibits anticancer activity against lung cancer and multiple myeloma .
loading...
    loading...
Cat. No.: HY-161840
Target:  

FGFR

Research Areas:  

Cancer

Antitumor agent-176 (Compound 22), an antitumor agent, can effectively bind to FGF2 and inhibit the activation of fibroblast growth factor receptor (FGFR) in multiple myeloma (MM) cells, exhibiting significant antitumor activity both in vivo and in vitro against MM .
loading...
    loading...
Cat. No.: HY-P991639

Target:  

Apoptosis

Research Areas:  

Cancer

BIW-8962 is a humanized anti-ganglioside GM2 antibody. BIW-8962 exhibits ADCC/CDC activity against multiple myeloma cells. BIW-8962 demonstrates potent anti-tumor activity in mouse xenograft models. BIW-8962 is indicated for research in myeloma and other cancers .
loading...
    loading...